ITMI981741A0 - Formulazioni farmaceutiche di beclometasone dipropinato per il trattamento di malettie infiammatorie croniche della mucosa intestinae - Google Patents

Formulazioni farmaceutiche di beclometasone dipropinato per il trattamento di malettie infiammatorie croniche della mucosa intestinae

Info

Publication number
ITMI981741A0
ITMI981741A0 IT98MI001741A ITMI981741A ITMI981741A0 IT MI981741 A0 ITMI981741 A0 IT MI981741A0 IT 98MI001741 A IT98MI001741 A IT 98MI001741A IT MI981741 A ITMI981741 A IT MI981741A IT MI981741 A0 ITMI981741 A0 IT MI981741A0
Authority
IT
Italy
Prior art keywords
intestinae
dipropinate
beclometasone
mucosa
treatment
Prior art date
Application number
IT98MI001741A
Other languages
English (en)
Inventor
Paolo Chiesi
Rossella Musa
Eva Bernini
Gian Nicola Castiglione
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI981741A0 publication Critical patent/ITMI981741A0/it
Priority to IT1998MI001741A priority Critical patent/IT1301947B1/it
Priority to PCT/EP1999/005160 priority patent/WO2000006132A2/en
Priority to AU54119/99A priority patent/AU5411999A/en
Priority to AT99940025T priority patent/ATE296092T1/de
Priority to ES99940025T priority patent/ES2243068T3/es
Priority to DK99940025T priority patent/DK1100481T3/da
Priority to EP99940025A priority patent/EP1100481B1/en
Priority to AT04020016T priority patent/ATE398454T1/de
Priority to DE69938939T priority patent/DE69938939D1/de
Priority to EP04020016A priority patent/EP1486209B1/en
Priority to PT99940025T priority patent/PT1100481E/pt
Priority to DE69925491T priority patent/DE69925491T2/de
Publication of ITMI981741A1 publication Critical patent/ITMI981741A1/it
Application granted granted Critical
Publication of IT1301947B1 publication Critical patent/IT1301947B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IT1998MI001741A 1998-07-28 1998-07-28 Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa IT1301947B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT1998MI001741A IT1301947B1 (it) 1998-07-28 1998-07-28 Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
EP99940025A EP1100481B1 (en) 1998-07-28 1999-07-20 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
DE69938939T DE69938939D1 (de) 1998-07-28 1999-07-20 Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen
AT99940025T ATE296092T1 (de) 1998-07-28 1999-07-20 Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen
ES99940025T ES2243068T3 (es) 1998-07-28 1999-07-20 Formulaciones farmaceuticas que comprenden beclometasona dipropionato para el tratamiento de la enfermedad intestinal inflamatoria.
DK99940025T DK1100481T3 (da) 1998-07-28 1999-07-20 Farmaceutiske formuleringer omfattende beclomethasondipropionat til behandling af inflammatoriske tarmsygdomme
PCT/EP1999/005160 WO2000006132A2 (en) 1998-07-28 1999-07-20 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
AT04020016T ATE398454T1 (de) 1998-07-28 1999-07-20 Pharmazeutische zusammensetzung enthaltend beclomethason-dipropional zur behandlung entzündlicher darmerkrankungen
AU54119/99A AU5411999A (en) 1998-07-28 1999-07-20 Pharmaceutical formulations for the treatment of inflammatory bowel disease
EP04020016A EP1486209B1 (en) 1998-07-28 1999-07-20 Pharmaceutical formulations for the treatment of inflammatory bowel disease
PT99940025T PT1100481E (pt) 1998-07-28 1999-07-20 Formulacoes farmaceuticas compreendendo dipropionato de beclometasona para o tratamento de doencas inflamatorias do intestino
DE69925491T DE69925491T2 (de) 1998-07-28 1999-07-20 Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI001741A IT1301947B1 (it) 1998-07-28 1998-07-28 Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa

Publications (3)

Publication Number Publication Date
ITMI981741A0 true ITMI981741A0 (it) 1998-07-28
ITMI981741A1 ITMI981741A1 (it) 2000-01-28
IT1301947B1 IT1301947B1 (it) 2000-07-20

Family

ID=11380533

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI001741A IT1301947B1 (it) 1998-07-28 1998-07-28 Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa

Country Status (9)

Country Link
EP (2) EP1486209B1 (it)
AT (2) ATE296092T1 (it)
AU (1) AU5411999A (it)
DE (2) DE69925491T2 (it)
DK (1) DK1100481T3 (it)
ES (1) ES2243068T3 (it)
IT (1) IT1301947B1 (it)
PT (1) PT1100481E (it)
WO (1) WO2000006132A2 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157921A0 (en) * 2001-03-15 2004-03-28 Enteron Pharmaceuticals Inc Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
AU2003270815A1 (en) * 2002-09-20 2004-04-08 The Board Of Regents Of The University Of Texas System Treatment of irritable bowel syndrome and related bowel diseases
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350690A (en) * 1980-10-27 1982-09-21 Cressington Investments Ltd. Steroid composition
IT1222414B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
WO1992016214A1 (en) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
HU213229B (en) * 1991-06-07 1997-03-28 Byk Nederland Bv Process for preparing enema preparation containing 5-aminosalicylic acid
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
CA2244421A1 (en) * 1996-01-16 1997-07-24 Advanced Polymer Systems, Inc. Topical delivery of drugs to the lower gastrointestinal tract
CA2304948C (en) * 1997-09-26 2009-12-29 Medeva Europe Limited Pharmaceutical composition for the treatment of inflammatory bowel disease

Also Published As

Publication number Publication date
ATE398454T1 (de) 2008-07-15
PT1100481E (pt) 2005-09-30
EP1486209B1 (en) 2008-06-18
DK1100481T3 (da) 2005-09-05
ES2243068T3 (es) 2005-11-16
IT1301947B1 (it) 2000-07-20
EP1486209A2 (en) 2004-12-15
ATE296092T1 (de) 2005-06-15
EP1486209A3 (en) 2004-12-22
AU5411999A (en) 2000-02-21
DE69938939D1 (de) 2008-07-31
ITMI981741A1 (it) 2000-01-28
DE69925491D1 (de) 2005-06-30
EP1100481B1 (en) 2005-05-25
WO2000006132A3 (en) 2000-04-27
DE69925491T2 (de) 2006-02-02
EP1100481A2 (en) 2001-05-23
WO2000006132A2 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
CY2014019I1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO20044054L (no) Administrering av midler for behandling av betennelse
ID23554A (id) Formulasi-formulasi intranasal untuk pengobatan penyakit-penyakit seksual
BR9710372A (pt) Composto composi-Æo farmac-utica e processos para o tratamento de uma doen-a inflamatÄria e de doen-as mediadas pela cliclooxigenase
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20042842L (no) Farmasoytiske formuleringer av platina-derivat
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
ITMI20001051A0 (it) Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari
IT1291340B1 (it) Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
ITMI981741A0 (it) Formulazioni farmaceutiche di beclometasone dipropinato per il trattamento di malettie infiammatorie croniche della mucosa intestinae
ITMI20000050A0 (it) Procedimento per la preparazione della 5-carbossiftalide
IL137598A (en) Oral formulations for treatment of chronic inflammatory disorders of the gastrointestinal tract
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
ID30249A (id) Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah
IT1313567B1 (it) Uso della n-acetil-cisteina per la preparazione di composizionifarmaceutiche topiche per il trattamento di patologie allergiche delle
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi
ITTO20020166U1 (it) Dispositivo terapeutico per il trattamento di sintomi provocati da malattie
AU2002348105A1 (en) Oral dosage forms for improving the bioavailability of therapeutic agents
DE50307521D1 (de) Arzneimittel zur behandlung des "systemic inflammatory response syndrome"
ITMI20000898A0 (it) Derivati di colina per il trattamento della malattia di alzheimer

Legal Events

Date Code Title Description
0001 Granted